Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 8/2015

01-08-2015 | Psychosocial Aspects (KK Hood and S Jaser, Section Editors)

Anxiety in Children and Adolescents With Type 1 Diabetes

Authors: Shideh Majidi, Kimberly A. Driscoll, Jennifer K. Raymond

Published in: Current Diabetes Reports | Issue 8/2015

Login to get access

Abstract

Although anxiety is a normal and developmentally appropriate experience of childhood and anxiety disorders are among the most commonly diagnosed disorders, the prevalence of anxiety symptomatology and anxiety disorders in children with type 1 diabetes (T1D) is not well documented. Most studies have focused on anxiety-related syndromes associated with T1D including fear of hypoglycemia, specific phobia of needles (i.e., needle anxiety), and anxiety related to uptake of new and sophisticated diabetes technology (e.g., continuous glucose monitors, continuous subcutaneous infusion therapy), but the extant literature is sparse, and more research is greatly needed. Identification, prevention, and treatment of anxiety are critical to providing comprehensive diabetes care and management. This review provides a summary of the literature focused on anxiety in children and adolescents with T1D with suggestions for future research and clinical implications.
Literature
1.••
Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 2015;56:345–65. This article provides an up to date overview of the worldwide prevalence of mental disorders in youth with estimates of 6.5 % for anxiety, 2.6 % for depression, and 3.4 % for ADHD.PubMedCrossRef
2.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2014.
3.
March JS, Parker JD, Sullivan K, Stallings P, Conners CK. The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry. 1997;36:554–65.PubMedCrossRef
4.
Birmaher B, Brent DA, Chiappetta L, Bridge J, Monga S, Baugher M. Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry. 1999;38:1230–6.PubMedCrossRef
5.
Kaufman J, Birmaher B, Brent DA, Ryan ND, Rao U. K-Sads-Pl. J Am Acad Child Adolesc Psychiatry. 2000;3910:1208.CrossRef
6.
Seligman LD, Ollendick TH, Langley AK, Baldacci HB. The utility of measures of child and adolescent anxiety: a meta-analytic review of the revised children’s manifest anxiety scale, the state-trait anxiety inventory for children, and the child behavior checklist. J Clin Child Adolesc Psychol. 2004;33:557–65.PubMedCrossRef
7.
8.
Adal E, Onal Z, Ersen A, Yalcin K, Onal H, Aydin A. Recognizing the psychosocial aspects of type 1 diabetes in adolescents. J Clin Res Pediatr Endocrinol. 2015;7:57–62.PubMedCrossRef
9.
American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38(Supplement 1):S70–6.CrossRef
10.
Plener PL, Molz E, Berger G, Schober E, Monkemoller K, Denzer C, et al. Depression, metabolic control, and antidepressant medication in young patients with type 1 diabetes. Pediatr Diabetes. 2015;16:58–66.PubMedCrossRef
11.
Hilliard ME, Herzer M, Dolan LM, Hood KK. Psychological screening in adolescents with type 1 diabetes predicts outcomes one year later. Diabetes Res Clin Pract. 2011;94:39–44.PubMedCentralPubMedCrossRef
12.••
Hood KK, Beavers DP, Yi-Frazier J, Bell R, Dabelea D, McKeown RE, et al. Psychosocial burden and glycemic control during the first 6 years of diabetes: results from the SEARCH for Diabetes in Youth study. J Adolesc Health. 2014;55:498–504. This study demonstrated that in a large sample of youth with type 1 diabetes, significant deterioration in glycemic control occurs in the first 6 years and that poor diabetes-specific quality of life is a significant contributor.PubMedCrossRef
13.
Stewart SM, Rao U, Emslie GJ, Klein D, White PC. Depressive symptoms predict hospitalization for adolescents with type 1 diabetes mellitus. Pediatrics. 2005;115:1315–9.PubMedCrossRef
14.
Clayton KM, Stewart SM, Wiebe DJ, McConnel CE, Hughes CW, White PC. Maternal depressive symptoms predict adolescent healthcare utilization and charges in youth with type 1 diabetes (T1D). Health Psychol. 2013;32:1013–22.PubMedCrossRef
15.
Pollock M, Kovacs M, Charron-Prochownik D. Eating disorders and maladaptive dietary/insulin management among youths with childhood-onset insulin-dependent diabetes mellitus. J Am Acad Child Adolesc Psychiatry. 1995;34:291–6.PubMedCrossRef
16.
Kovacs M, Goldston D, Obrosky DS, Bonar LK. Psychiatric disorders in youths with IDDM: rates and risk factors. Diabetes Care. 1997;20:36–44.PubMedCrossRef
17.
Northam EA, Matthews LK, Anderson PJ, Cameron FJ, Werther GA. Psychiatric morbidity and health outcome in type 1 diabetes—perspectives from a prospective longitudinal study. Diabet Med. 2005;22:152–7.PubMedCrossRef
18.
Sivertsen B, Petrie KJ, Wilhelmsen-Langeland A, Hysing M. Mental health in adolescents with type 1 diabetes: results from a large population-based study. BMC Endocr Disord. 2014;14:83.PubMedCentralPubMedCrossRef
19.
Dantzer C, Swendsen J, Maurice-Tison S, Salamon R. Anxiety and depression in juvenile diabetes: a critical review. Clin Psychol Rev. 2003;23:787–800.PubMedCrossRef
20.
Herzer M, Hood KK. Anxiety symptoms in adolescents with type 1 diabetes: association with blood glucose monitoring and glycemic control. J Pediatr Psychol. 2010;35:415–25.PubMedCentralPubMedCrossRef
21.
Nixon R, Pickup JC. Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control? Diabetes Technol Ther. 2011;13:93–8.PubMedCrossRef
22.••
Hawkes CP, McDarby V, Cody D. Fear of hypoglycemia in parents of children with type 1 diabetes. J Paediatr Child Health. 2014;50:639–42. This study found that fear of hypoglycemia was highest among parents of children ages 6–11 years.PubMedCrossRef
23.
Gonder-Frederick LA, Cox DJ, Ritterband LM. Diabetes and behavioral medicine: the second decade. J Consult Clin Psychol. 2002;70:611–25.PubMedCrossRef
24.
Shepard JA, Vajda K, Nyer M, Clarke W, Gonder-Frederick L. Understanding the construct of fear of hypoglycemia in pediatric type 1 diabetes. J Pediatr Psychol. 2014;39:1115–25.PubMedCrossRef
25.
Gonder-Frederick LA, Fisher CD, Ritterband LM, Cox DJ, Hou L, DasGupta AA, et al. Predictors of fear of hypoglycemia in adolescents with type 1 diabetes and their parents. Pediatr Diabetes. 2006;7:215–22.PubMedCrossRef
26.
Al Hayek AA, Robert AA, Braham RB, Issa BA, Al Sabaan FS. Predictive risk factors for fear of hypoglycemia and anxiety-related emotional disorders among adolescents with type 1 diabetes. Med Princ Pract. 2015.
27.
Patton SR, Dolan LM, Henry R, Powers SW. Fear of hypoglycemia in parents of young children with type 1 diabetes mellitus. J Clin Psychol Med Settings. 2008;15:252–9.PubMedCentralPubMedCrossRef
28.••
Barnard K, Thomas S, Royle P, Noyes K, Waugh N. Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review. BMC Pediatr. 2010;10:50. This review article demonstrated that parents of children with type 1 diabetes experience high levels of fear of hypoglycemia, which impacts parental physical health and quality of life. Parents engage in hypoglycemic avoidance behaviors, which impacts glycemic control.PubMedCentralPubMedCrossRef
29.
Freckleton E, Sharpe L, Mullan B. The relationship between maternal fear of hypoglycaemia and adherence in children with type-1 diabetes. Int J Behav Med. 2014;21:804–10.PubMedCrossRef
30.
Haugstvedt A, Wentzel-Larsen T, Graue M, Sovik O, Rokne B. Fear of hypoglycaemia in mothers and fathers of children with type 1 diabetes is associated with poor glycaemic control and parental emotional distress: a population-based study. Diabet Med. 2010;27:72–8.PubMedCrossRef
31.
Cox DJ, Gonder-Frederick L, Polonsky W, Schlundt D, Kovatchev B, Clarke W. Blood glucose awareness training (BGAT-2): long-term benefits. Diabetes Care. 2001;24:637–42.PubMedCrossRef
32.••
Vallis M, Jones A, Pouwer F. Managing hypoglycemia in diabetes may be more fear management than glucose management: a practical guide for diabetes care providers. Curr Diabetes Rev. 2014;10:364–70. This article provides an overview of the psychological consequences of hypoglycemia and strategies that can be implemented as treatment (i.e., exposure).PubMedCrossRef
33.
Simmons JH, McFann KK, Brown AC, Rewers A, Follansbee D, Temple-Trujillo RE, et al. Reliability of the diabetes fear of injecting and self-testing questionnaire in pediatric patients with type 1 diabetes. Diabetes Care. 2007;30:987–8.PubMedCrossRef
34.••
Cemeroglu AP, Can A, Davis AT, Cemeroglu O, Kleis L, Daniel MS, et al. Fear of needles in children with type 1 diabetes mellitus on multiple daily injections and continuous subcutaneous insulin infusion. Endocr Pract. 2015;21:46–53. This study used the Diabetes Fear of Injecting and Self-Testing Questionnaire to assess fear of needles in children with type 1 diabetes. Fear of testing was found in 10 % of the sample, whereas fear of injecting was found in 33 %.PubMedCrossRef
35.
Howe CJ, Ratcliffe SJ, Tuttle A, Dougherty S, Lipman TH. Needle anxiety in children with type 1 diabetes and their mothers. MCN Am J Matern Child Nurs. 2011;36:25–31.PubMedCrossRef
36.••
Uman LS, Birnie KA, Noel M, Parker JA, Chambers CT, McGrath PJ, et al. Psychological interventions for needle-related procedural pain and distress in children and adolescents. Cochrane Database Syst Rev. 2013;10. This article reviews 39 trials on managing needle pain associated with venipuncture, intravenous line insertion, and immunization. There is strong evidence for the use of distraction and hypnosis for needle-related pain and distress, but more research is needed for other approaches (e.g., cognitive behavioral therapy, parent coaching and distraction).
37.••
Markowitz JT, Harrington KR, Laffel LM. Technology to optimize pediatric diabetes management and outcomes. Curr Diab Rep. 2013;13:877–85. This article provides a review of the psychosocial factors associated with use of new diabetes technology.PubMedCrossRef
38.
Kaufman FR, Halvorson M, Kim C, Pitukcheewanont P. Use of insulin pump therapy at nighttime only for children 7–10 years of age with type 1 diabetes. Diabetes Care. 2000;23:579–82.PubMedCrossRef
39.
Mauras N, Beck R, Xing D, Ruedy K, Buckingham B, Tansey M, et al. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care. 2012;35:204–10.PubMedCentralPubMedCrossRef
40.
Cemeroglu AP, Stone R, Kleis L, Racine MS, Postellon DC, Wood MA. Use of a real-time continuous glucose monitoring system in children and young adults on insulin pump therapy: patients’ and caregivers’ perception of benefit. Pediatr Diabetes. 2010;11:182–7.PubMedCrossRef
41.
Barnard KD, Wysocki T, Allen JM, Elleri D, Thabit H, Leelarathna L, et al. Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents. BMJ Open Diabetes Res Care. 2014;2, e000025.PubMedCentralPubMedCrossRef
42.
Rooksby M, Elouafkaoui P, Humphris G, Clarkson J, Freeman R. Internet-assisted delivery of cognitive behavioural therapy (CBT) for childhood anxiety: systematic review and meta-analysis. J Anxiety Disord. 2015;29:83–92.PubMedCrossRef
43.
Hackworth NJ, Matthews J, Burke K, Petrovic Z, Klein B, Northam EA, et al. Improving mental health of adolescents with type 1 diabetes: protocol for a randomized controlled trial of the Nothing Ventured Nothing Gained online adolescent and parenting support intervention. BMC Public Health. 2013;13:1185.PubMedCentralPubMedCrossRef
44.
Spaulding R, Cain S, Sonnenschein K. Urban telepsychiatry: uncommon service for a common need. Child Adolesc Psychiatr Clin N Am. 2011;20:29–39.PubMedCrossRef
Metadata
Title
Anxiety in Children and Adolescents With Type 1 Diabetes
Authors
Shideh Majidi
Kimberly A. Driscoll
Jennifer K. Raymond
Publication date
01-08-2015
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 8/2015
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-015-0619-0

Other articles of this Issue 8/2015

Current Diabetes Reports 8/2015 Go to the issue

Psychosocial Aspects (KK Hood and S Jaser, Section Editors)

Diabetes Among Refugee Populations: What Newly Arriving Refugees Can Learn From Resettled Cambodians

Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor)

The Development, Validation, and Utility of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS)

Psychosocial Aspects (KK Hood and S Jaser, Section Editors)

A Review of Adolescent Adherence in Type 1 Diabetes and the Untapped Potential of Diabetes Providers to Improve Outcomes

Psychosocial Aspects (KK Hood and S Jaser, Section Editors)

Practical Strategies to Enhance Executive Functioning and Strengthen Diabetes Management Across the Lifespan

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

Health Effects of Fructose and Fructose-Containing Caloric Sweeteners: Where Do We Stand 10 Years After the Initial Whistle Blowings?

Microvascular Complications—Nephropathy (T Isakova, Section Editor)

Weight Loss Interventions and Progression of Diabetic Kidney Disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits